The National Institutes of Health (NIH), through the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), awarded a $669,321 project grant to the Regents of the University of California at Riverside (UC Riverside). The grant supports a 1-year study to characterize new and emerging ingredients, acids, toxicants, and indicators of non-tobacco nicotine in electronic cigarette (e-cigarette) products. The research will involve: Analyzing 600 commercial...
This federal Project Grant award, provided under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) by the National Institutes of Health Office of the Director, is funding a study to investigate the exposure and health effects of chemical constituents from electronic cigarette (e-cigarette) use among young adults. The primary objectives are to: 1) evaluate the relationship between e-cigarette use and exposure to metals and aldehydes, 2) assess the...
This Project Grant award of $622,957 from the National Institutes of Health (NIH) Office of the Director, under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077), supports research by Duke University to investigate the chemical composition and behavioral effects of novel tobacco products, including oral nicotine pouches and "non-menthol" cigarettes. The study aims to analyze the flavors, sweeteners, and nicotine forms in these products, and...
This Project Grant award from the National Institutes of Health (NIH) under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) provides $1,197,896 to the University of Oklahoma Health Sciences Center to conduct a longitudinal study examining the impact of electronic nicotine delivery system (ENDS) product characteristics on use behaviors and abuse liability among young adults. The study will utilize a combination of traditional survey methods and...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA Program 93.077 - Family Smoking Prevention and Tobacco Control Act Regulatory Research provides $188,913 to Virginia Commonwealth University (VCU) from August 1, 2024 to July 31, 2029. The purpose of the grant is to assess perceptions of the continuum of risk among socioeconomically disadvantaged adult smokers, design and test educational messages about the relative risks of...
This federal Project Grant award, valued at $723,676 and awarded by the National Institute on Drug Abuse (NIDA) under CFDA program 93.279 "Drug Use and Addiction Research Programs", supports research to investigate the long-term effects of electronic cigarettes (e-cigarettes) on brain health. The grant will fund a study comparing brain and physiological measures between former smokers who switched to e-cigarettes and those who quit smoking entirely. The research aims to shed light on...
This $2,490,060 Cooperative Agreement award from the National Institutes of Health (NIH) Office of the Director under the Family Smoking Prevention and Tobacco Control Act Regulatory Research program (CFDA 93.077) supports research to optimize public health communication strategies on the continuum of risk for tobacco products. The project aims to assess the effects of FDA tobacco product risk continuum messaging on adult combustible tobacco users and youth/young adult tobacco users or...
This $1,257,395 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI)'s Cardiovascular Diseases Research program (CFDA 93.837) aims to quantify the long-term effects of e-cigarette use on cardiovascular and pulmonary health. The study will recruit 400 long-term e-cigarette users and 200 non-users to undergo comprehensive biomarker assessments over 36 months, including measures of cardiovascular health, lung function, and nicotine dependence. The primary objectives are to...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $187,500.00 to North Carolina Central University (NCCU) to assess the immunosuppressive effects of e-cigarette (e-cig) usage and its impact on susceptibility to pulmonary infections. The key objectives are to: 1) model lung cell immune dysfunction using human bronchial epithelial cells, 2) assess immune cell involvement and lung...
This $619,477 federal Project Grant awarded by the National Institute of Environmental Health Sciences (NIEHS) under the Environmental Health (CFDA 93.113) program supports research to investigate the impact of electronic cigarette (e-cigarette) exposure, both direct and in-utero, on vascular function and cognitive decline. The research, conducted by the West Virginia University Research Corporation, aims to establish the dose-dependent effects of e-cigarette exposure on vascular dysfunction and...
This federal Project Grant award from the National Institutes of Health (NIH) Office of the Director under CFDA 93.077 Family Smoking Prevention and Tobacco Control Act Regulatory Research program provides $3,230,000 to The Regents of the University of California, San Francisco (UCSF) to investigate the cardiovascular effects of dual use of tobacco and nicotine delivery products like cigarettes and e-cigarettes. The project aims to (1) understand the cardiovascular health effects of dual use in rats, (2) examine the cardiovascular effects of smoking and e-cigarette dual use in humans, and (3) identify biomarker patterns specific to exclusive or dual use. This research seeks to generate scientific evidence to inform the Food and Drug Administration's (FDA) regulation of tobacco products and their potential health impacts, particularly the synergistic effects of using multiple nicotine delivery systems concurrently. The award period runs from September 15, 2024 to June 30, 2029.